Novel Strategies for Reducing Burn Scar Itch

Recruiting Phase 3 Interventional Study
Burn Scar Itch Scarring Wound
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
44 (estimated)
Sponsor
The University of Texas Medical Branch, Galveston · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Participants must meet all the inclusion criteria in order to be eligible to participate in the study. * Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures. * Adults: ≥18 to \<80 years of age. * …
Contacts

Lindsey Allen, RN

409-266-2678

listurm@utmb.edu

CONTACT